
<!DOCTYPE html>
<html lang="en">
<head>
<!-- Meta-Tag -->
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">

<title>TolsuraHCP</title>

<meta name="apple-mobile-web-app-status-bar-style" content="#cd9f26">
<meta name="theme-color" content="#cd9f26" />

<!-- googlefont -->
<link rel="preconnect" href="https://fonts.gstatic.com">
<link href="https://fonts.googleapis.com/css2?family=Source+Sans+Pro:ital,wght@0,400;0,600;0,700;1,400;1,600;1,700&display=swap" rel="stylesheet">

<!-- favicon -->
<link rel="icon" href="assets/img/favicon.ico">

<!-- CSS -->
<link rel="stylesheet" href="assets/css/bootstrap.min.css">
<link rel="stylesheet" href="assets/css/style.css">
</head>
<body class="home">
<!-- Announcement Bar Start -->
<div class="announcement__bar text-center text-white pt-lg-3 pb-lg-3 pt-2 pb-2">
    <div class="container">
        <div class="d-flex justify-content-center align-items-center">
            <div class="announcement__title"><strong>JOIN US FOR A SPECIAL WEBINAR</strong> ABOUT OUR BREAKTHROUGH ANTIFUNGAL INNOVATION, TOLSURA</div>
            <a href="#" class="btn btn-transparent"><span class="d-none d-lg-block">REGISTER TO JOIN</span><img class="d-block d-lg-none" src="assets/img/icons-arrow_right.svg" alt="Icons Arrow Right"> </a>
        </div>
    </div>
</div>
<!-- Announcement Bar End -->

<header class="transparent">
    <div class="container">
        <div class="d-flex align-items-center">
            <a class="nav__toggle" href="#" aria-expanded="false" aria-label="Toggle navigation"><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span></a>
            <a href="index.html" class="logo"><img src="assets/img/TOLSURA_LOGO.png" alt="Go To Tolsura"></a>
            <div class="nav__block flex-column">
                <div class="nav-wrapper d-flex flex-lg-column-reverse">
                    <div class="primary__nav">
                        <ul>
                            <li class="menu-item menu-item-type-post_type menu-item-object-page current-menu-item current_page_item"><a href="infection-overview.html">INFECTIONS OVERVIEW</a></li>
                            <li class="menu-item menu-item-type-post_type menu-item-object-page"><a href="abouttolsura.html">ABOUT TOLSURA</a></li>
                            <li class="menu-item menu-item-type-post_type menu-item-object-page"><a href="#">BENEFITS OF TOLSURA</a>
                                <ul>
                                    <li class="menu-item menu-item-type-post_type menu-item-object-page"><a href="bioavailability.html">BIOAVAILABILITY</a></li>
                                    <li class="menu-item menu-item-type-post_type menu-item-object-page"><a href="absorption.html">ABSORPTION</a></li>
                                    <li class="menu-item menu-item-type-post_type menu-item-object-page current-menu-item current_page_item"><a href="#">THERAPEUTIC LEVELS</a></li>
                                </ul>
                            </li>
                            <li class="menu-item menu-item-type-post_type menu-item-object-page"><a href="#">SAFETY</a></li>
                            <li class="menu-item menu-item-type-post_type menu-item-object-page"><a href="#">DOSING</a></li>
                            <li class="menu-item menu-item-type-post_type menu-item-object-page"><a href="#">SAVINGS</a></li>
                        </ul>
                    </div>
                    <div class="secondary__nav mb-md-3">
                        <ul>
                            <li class="menu-item menu-item-type-post_type menu-item-object-page"><a href="#isi-expand">Important Safety Information</a></li>
                            <li class="menu-item menu-item-type-post_type menu-item-object-page"><a href="#">Prescribing Information</a></li>
                            <li class="menu-item menu-item-type-post_type menu-item-object-page"><a href="#">Patient Site</a></li>
                        </ul>
                    </div>
                </div>
            </div>
            <div class="ml-auto">
                <a class="btn" data-toggle="modal" data-target="#myModal">Contact A Representative</a>
            </div> 
        </div>
    </div>
</header>

<!-- HEADER START -->
<div class="section hero__banner">
    <div class="banner__image lazyload" data-bgset="assets/img/Hero-Captain_Image_mobile-2x.png [(max-width: 767px)] | assets/img/Hero_Superman_Hero-image.png">
    </div>
    <div class="hero__content text-white">
        <div class="container">
            <div class="float-left">
                <h1>BATTLES AGAINST FUNGAL INFECTIONS CAN LEAVE YOU WISHING YOU HAD SUPERPOWERS.</h1>
                <p>Try the next best thing. With its breakthrough SUBA® technology, TOLSURA offers an evolution in itraconazole antifungal treatment.</p>
                <a href="#" class="btn">ABOUT TOLSURA</a>
            </div>
        </div>
    </div>
    <div class="banner__label d-none d-lg-block d-md-none">
        SOME HEROS COME IN SMALL SIZES
    </div>
</div>
<!-- HEADER END -->

<!-- skip to content link start -->
<a class="sr-only skip-link screen-reader-text" href="#maincontent">Skip to the content</a>
<!-- skip to content link end -->

<!-- PAGE CONTENT START -->
<main id="maincontent" class="pagecontent">
    <div class="section capsule__description position-relative lazyload" data-bgset="assets/img/Tolsura-bottle_video-screenshot-mobile.png [(max-width: 767px)] | assets/img/Tolsura-bottle_video-screenshot-desktop.png">
        <div class="capsule__content pt-150">
            <div class="container">
                <div class="row mb-5">
                    <div class="col-lg-5">
                        <div class="article__content">
                            <h2>ADVANCED ANTIFUNGAL INNOVATION YOU CAN DEPEND ON</h2>
                            <p><strong>FOR ENDEMIC AND OPPORTUNISTIC FUNGAL INFECTIONS</strong> TOLSURA 65 mg capsules offer the efficacy of itraconazole capsules with improved absorption and less variability in plasma levels <sup>1</sup></p>
                        </div>
                    </div>
                </div>
                <div class="row article__card-row pt-200">
                    <div class="col-lg-4">
                        <div class="article__card bg-white position-relative">
                            <img src="assets/img/Triangle-marker_2.svg" alt="Tolsura Bioavailability">
                            <h3>TOLSURA has up to <span class="green-color"><strong>90% bioavailability</strong></span></h3>
                            <p>approximately twice that of conventional itraconazole, with improved absorption and reduced plasma variability<sup>2</sup>.</p>
                            <div class="btn-block text-center"><a href="bioavailability.html" class="btn">BIOAVAILABILITY</a></div>
                        </div>
                    </div>
                    <div class="col-lg-4">
                        <div class="article__card bg-white position-relative">
                            <img src="assets/img/Triangle-marker_2.svg" alt="Tolsura Suba Technology">
                            <h3>TOLSURA's SUBA technology offers <span class="green-color"><strong>significantly improved solubility</strong></span></h3>
                            <p>in the higher pH of the upper small intestine, resulting in improved absorption<sup>3</sup> which is not reduced with proton pump inhibitor use<sup>1,4,5,*</sup>.</p>
                            <div class="btn-block text-center"><a href="absorption.html" class="btn">ABSORPTION</a></div>
                        </div>
                        <div class="note__text text-center pt-3">* Monitor for side effects as dosing with a proton pump inhibitor may increase peak and overall exposure of itraconazole</div>
                    </div>
                    <div class="col-lg-4">
                        <div class="article__card bg-white position-relative">
                            <img src="assets/img/Triangle-marker_2.svg" alt="Tolsura Treatment">
                            <h3>81% of subjects treated with TOLSURA <span class="green-color"><strong>achieved therapeutic blood levels<sup>†</sup></strong></span></h3>
                            <p>compared to 44% taking conventional itraconazole capsules.<sup>1,6</sup> With TOLSURA, therapeutic levels are achieved and maintained in both fed and fasted states (FDA dosing instructions require taking with food)<sup>4,6,7</sup>.</p>
                            <div class="btn-block text-center"><a href="therapeutic-levels.html" class="btn">THERAPEUTIC LEVELS</a></div>
                        </div>
                        <div class="note__text text-center pt-3">†mean trough level of conventional itraconazole, 1,034 ng/mL.</div>
                    </div>    
                </div>
            </div>
        </div>
    </div>
    <div class="section tolsura__conventional pt-150 pb-100">
        <div class="container">
            <h2><strong>TOLSURA VS. CONVENTIONAL ITRACONAZOLE<sup>3,8,9</sup>:</strong></h2>
            <div class="row pt-md-4">
                <div class="col-lg-5 col-md-6">
                    <img class="img-fluid mb-md-0 mb-4" src="assets/img/capsule-size_graph.png" alt="TOLSURA VS. CONVENTIONAL ITRACONAZOLE">
                </div>
                <div class="col-lg-7 col-md-6">
                    <div class="dose__list pl-100">
                        <ul class="mt-md-3 mb-md-4">
                            <li>REDUCED DOSE</li>
                            <li>SIMILAR TOTAL AND PEAK ITRACONAZOLE EXPOSURE WITH LESS DRUG</li>
                            <li>~2X BIOAVAILABILITY</li>
                            <li>SIMILAR SAFETY PROFILE</li>
                        </ul>
                        <a href="#" class="btn mt-5">LEARN MORE</a>
                    </div>
                </div>
            </div>
        </div>
    </div>         

    <!-- Video Section Start -->
    <div id="section3" class="section p-0">
        <script src="https://fast.wistia.com/embed/medias/jqf8u63qgs.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_jqf8u63qgs videoFoam=true" style="height:100%;position:relative;width:100%"><div class="wistia_swatch" style="height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;"><img src="https://fast.wistia.com/embed/medias/jqf8u63qgs/swatch" style="filter:blur(5px);height:100%;object-fit:contain;width:100%;" alt="" aria-hidden="true" onload="this.parentNode.style.opacity=1;" /></div></div></div></div>
    </div>
    <!-- Video Section End -->

    <div class="section gray__bg pt-5 pb-100">
        <div class="container">
            <div class="row">
                <div class="col-md-6">
                    <img class="img-fluid mb-md-0 mb-5" src="assets/img/graph-1-2x.png" alt="Conventional Itraconazole">
                </div>
                <div class="col-md-6">
                    <img class="img-fluid" src="assets/img/graph-2-2x.png" alt="SUBA Itraconazole">
                </div>
            </div>
        </div>
    </div>
    <div class="section tolsura__help pt-100 pb-100">
        <div class="primary__title pb-100">
            <div class="container">
                <h2>CAN TOLSURA HELP YOUR PATIENTS?</h2>
            </div>
        </div>
        <div class="article__content mt-5">
            <div class="container">
                <div class="row">
                    <div class="col-lg-7">
                        <h3><strong>TOLSURA IS SUITABLE FOR ADULT PATIENTS</strong> who have been diagnosed with histoplasmosis, blastomycosis or aspergillosis<sup>1,10,11</sup>, and</h3>
                        <div class="article__list mt-5">
                            <ul>
                                <li>Oral antifungal therapy is the appropriate choice for treatment<sup>1,10,11,12,13,14</sup></li>
                                <li>Want a reliable treatment to deliver and maintain consistent therapeutic levels<sup>17</sup></li>
                                <li>Patients who are immunocompromised and immunocompetent<sup>15,16</sup></li>
                                <li>Want the convenience of not having lifestyle and diet restraints<sup>17,18,19</sup>
                                    <ul>
                                        <li>E.g., no requirement for an acidic beverage or high-fat meal</li>
                                    </ul>
                                </li>
                                <li>Have gastrointestinal issues, or take a proton pump inhibitor<sup>3,18,19,20</sup></li>
                                <li>Want to take a lower dose of medication with a smaller capsule size without compromising on efficacy<sup>3,5,6</sup></li>
                            </ul>
                        </div>
                    </div>
                    <div class="col-lg-5">
                        <div class="tolsura__infection-graph mt-lg-0 mt-5">
                            <img class="img-fluid float-lg-right" src="assets/img/Tolsura_infections_infographic.png" alt="Tolsura Infections Infographics">
                        </div>
                    </div>
                </div>
            </div>
        </div>  
    </div>
    <div class="section tolsura__dose position-relative lazyload" data-bgset="assets/img/Female_Smiling_image_mobile.png [(max-width: 767px)] | assets/img/Female_Smiling_image.png">
        <div class="container">
            <div class="tolsura__dose-description text-white">
                <h2>CONVENIENT DOSING WITH TOLSURA</h2>
                <a href="#" class="btn mt-lg-5 mt-4">LEARN MORE</a>
            </div>
        </div>
    </div>
    <!-- The Modal -->
  <div class="modal" id="myModal">
    <div class="modal-dialog modal-lg">
      <div class="modal-content p-4">
        <!-- Modal Header -->
        <div class="modal-header">
          <button type="button" class="close" data-dismiss="modal"><img src="assets/img/Icons_close.svg" alt="close"></button>
          <div class="form-title" id="form-title">
             INTERESTED IN STARTING YOUR JOURNEY WITH TOLSURA?
             <span class="form-sub-title">
                Sign up for an introductory conversation with one of our representatives
             </span>
          </div>
        </div>
        
        <!-- Modal body -->
        <div class="modal-body">
           <form id="contact-form-popup" method="post">
             <div class="container">
                <div class="row">
                   <div class="col-md-6">
                      <div class="form-group">
                         <label for="firstname">First and Last Name*</label>
                         <input type="text" class="form-control" id="firstname" name="firstname" required="required">
                       </div>
                   </div>
                   <div class="col-md-6">
                      <div class="form-group">
                         <label for="phone">Phone*</label>
                         <input type="text" pattern="[0-9]{1}[0-9]{9}" class="form-control" id="phone"  name="phone" required="required">
                       </div>
                   </div>
                   <div class="col-md-6">
                      <div class="form-group">
                         <label for="jobtitle">Job Title*</label>
                         <div class="controlselect">
                             <select name="jobtitle" id="jobtitle" class="form-control" required="required">
                                 <option value="" selected disabled>Please select</option>
                                 <option value="Doctor of Medicine">Doctor of Medicine</option>
                                 <option value="Doctor of Osteopathy">Doctor of Osteopathy</option>
                                 <option value="Nurse Practitioner">Nurse Practitioner</option>
                                 <option value="Physician Assistant">Physician Assistant</option>
                                 <option value="Medical Assistant">Medical Assistant</option>
                                 <option value="Admin">Admin</option>
                                 <option value="Other">Other</option>
                             </select>
                         </div>
                       </div>
                   </div>
                   <div class="col-md-6">
                      <div class="form-group">
                         <label for="address">Address*</label>
                         <input type="text" class="form-control" id="address"  name="address" required="required">
                       </div>
                   </div>
                   <div class="col-md-6">
                      <div class="form-group">
                         <label for="specialty">Specialty*</label>
                         <div class="controlselect">
                             <select name="specialty" id="specialty" class="form-control" required="required">
                               <option value="" selected disabled>Please select</option>
                               <option value="Infectious Disease">Infectious Disease</option>
                               <option value="Pulmonary Disease">Pulmonary Disease</option>
                               <option value="Internal Medicine">Internal Medicine</option>
                               <option value="Family Medicine">Family Medicine</option>
                               <option value="Hematology/Oncology">Hematology/Oncology</option>
                               <option value="Other">Other</option>
                             </select>
                         </div>
                       </div>
                   </div>
                   <div class="col-md-6">
                      <div class="form-group">
                         <label for="city">City*</label>
                         <input type="text" class="form-control" id="city"  name="city" required="required">
                       </div>
                   </div>
                   <div class="col-md-6">
                      <div class="form-group">
                         <label for="email">Email*</label>
                         <input type="email" class="form-control" id="email"  name="email" required="required">
                       </div>
                   </div>
                   <div class="col-md-6">
                      <div class="row">
                         <div class="col-md-6">
                            <div class="form-group">
                               <label for="zip">ZIP*</label>
                               <input type="text" class="form-control" id="zip"  name="zip" required="required">
                             </div>
                         </div>
                         <div class="col-md-6">
                            <div class="form-group">
                               <label for="state">State*</label>
                               <div class="controlselect">
                                 <select name="state" id="state" class="form-control" required="required">
                                     <option value="" selected disabled>Please select</option>
                                       <option value="CA">California</option>
                                       <option value="CO">Colorado</option>
                                       <option value="CT">Connecticut</option>
                                       <option value="DC">Washington DC</option>
                                       <option value="DE">Delaware</option>
                                       <option value="FL">Florida</option>
                                       <option value="GA">Georgia</option>
                                       <option value="IA">Iowa</option>
                                       <option value="ID">Idaho</option>
                                       <option value="IL">Illinois</option>
                                       <option value="IN">Indiana</option>
                                       <option value="KS">Kansas</option>
                                       <option value="KY">Kentucky</option>
                                       <option value="LA">Louisiana</option>
                                       <option value="MA">Massachusetts</option>
                                       <option value="MD">Maryland</option>
                                       <option value="ME">Maine</option>
                                       <option value="MI">Michigan</option>
                                       <option value="MN">Minnesota</option>
                                       <option value="MO">Missouri</option>
                                       <option value="MS">Mississippi</option>
                                       <option value="MT">Montana</option>
                                       <option value="NC">North Carolina</option>
                                       <option value="ND">North Dakota</option>
                                       <option value="NE">Nebraska</option>
                                       <option value="NH">New Hampshire</option>
                                       <option value="NJ">New Jersey</option>
                                       <option value="NM">New Mexico</option>
                                       <option value="NV">Nevada</option>
                                       <option value="NY">New York</option>
                                       <option value="OH">Ohio</option>
                                       <option value="OK">Oklahoma</option>
                                       <option value="OR">Oregon</option>
                                       <option value="PA">Pennsylvania</option>
                                       <option value="RI">Rhode Island</option>
                                       <option value="SC">South Carolina</option>
                                       <option value="SD">South Dakota</option>
                                       <option value="TN">Tennessee</option>
                                       <option value="TX">Texas</option>
                                       <option value="UT">Utah</option>
                                       <option value="VA">Virginia</option>
                                       <option value="VT">Vermont</option>
                                       <option value="WA">Washington</option>
                                       <option value="WI">Wisconsin</option>
                                       <option value="WV">West Virginia</option>
                                       <option value="WY">Wyoming</option> 
                                     </select>
                               </div>
                             </div>
                         </div>
                      </div>
                      
                   </div>
                </div>
                <div class="row mt-4">
                   <div class="col-md-4 btn-warning-popup">
                      <img src="https://awareness.tolsura.com/l/153741/2021-01-20/43dkgf/153741/16111229975pdGm9Jm/warning_icon.svg" alt="warning"> This is a required field.
                   </div>
                   
                   <div class="col-md-8  text-right">
                      <span class="btn-info-popup">By clicking ‘Send' you agree to be contacted by phone by a sales representative of Mayne Pharma</span>
                      <button class="btn green-btn" onclick="formSubmit()">SEND NOW</button>
                   </div>
                </div>
             </div>
            </form>
            <!--For Thank you Part-->
            <div class="thank-you-popup text-center " id="thankyouPage">
                <div class="thank-you-msg" id="tymsg">
                    <div class="heading red-color mb-5">Thank You</div>
                    <div class="pt-4">One of our representatives will <br /> get in touch with you soon.</div>
                </div>
            </div>
        </div>
      </div>
    </div>
  </div>
</main>
<!-- PAGE CONTENT END -->

<!-- ISI BLOCK START -->
<div id="isi-expand" class="section pt-100">
    <div class="container pb-100">          
        <p>Indications and Important <br class="d-block d-lg-none d-md-none">  Safety Information  </p>
        <div class="warning-box">
            <p class="mb-0"><strong>BOXED WARNING</strong> <br /><strong>WARNING: CONGESTIVE HEART FAILURE and DRUG INTERACTIONS</strong></p>
            <ul class="bullet1 mb-1 mt-1">
            <li>» CONGESTIVE HEART FAILURE</li>
            </ul>
            <p class="mb-1 pl-3"><strong>TOLSURA can cause or exacerbate congestive heart failure (CHF). When itraconazole was administered intravenously to healthy human volunteers and dogs, negative inotropic effects were seen. </strong>If signs or symptoms of congestive heart failure occur or worsen during administration of TOLSURA, reassess the benefit and risk of continuing treatment.</p>
            <ul class="bullet1">
                <li> » DRUG INTERACTIONS</li>
            </ul>
            <ul class="bullet2">
                <li>Co-administration of certain drugs that are metabolized by human CYP3A4 enzymes are contraindicated with
                TOLSURA because plasma concentrations of such drugs are increased, which may also increase or prolong both the
                pharmacologic effects and/or adverse reactions to these drugs.</li>
                <li>Co-administration with colchicine, fesoterodine and solifenacin is contraindicated in subjects with varying degrees of renal or hepatic impairment, and</li>
                <li>Co-administration with eligustat is contraindicated in subjects taking strong or moderate CYP2D6 inhibitors. </li>
                <li>Increased plasma concentrations of some of these drugs caused by co-administration with TOLSURA can lead to QT prolongation and/or ventricular tachyarrhythmias, including occurrences of torsades de pointes, a potentially fatal arrhythmia.</li>
            </ul>
            <p class="mb-0"><strong>Indications and Usage</strong> </p>
            <p>TOLSURA is an azole antifungal indicated for the treatment of the following fungal infections in <strong>immunocompromised and non-immunocompromised</strong> adult patients:</p>
            <ul class="bullet2 ml-2">
                <li>Blastomycosis, pulmonary and extrapulmonary</li>
                <li>Histoplasmosis, including chronic cavitary pulmonary disease and disseminated, non-meningeal histoplasmosis, and</li>
                <li>Aspergillosis, pulmonary and extrapulmonary, in patients who are intolerant of or who are refractory to amphotericin B therapy </li>
            </ul>
            <p class="mb-0 mb-2 mt-4"><strong>Limitations of Use:</strong></p>
            <p class="mb-0">TOLSURA is not indicated for the treatment of onychomycosis.</p>
            <p class="mb-0">TOLSURA is NOT interchangeable or substitutable with other itraconazole products.</p>
            <p class="mb-0 mb-2 mt-4"><strong>Contraindications</strong></p>
            <p class="mb-0">Co-administration with certain drugs that either affect metabolism of itraconazole or whose metabolism is affected by itraconazole Hypersensitivity to itraconazole</p>
            <p class="mb-0 mb-2 mt-4"><strong>Warnings and Precautions</strong></p>
            <ul class="bullet2 ml-2">
                <li><strong>Hepatotoxicity:</strong> Serious hepatotoxicity, including liver failure and death, were reported with the use of itraconazole. Discontinue treatment if signs of liver dysfunction occur</li>
                <li><strong>Cardiac Dysrhythmias:</strong> Life-threatening cardiac dysrhythmias and/or sudden death have occurred in patients using certain drugs that are metabolized by human CYP450 enzymes concomitantly with oral itraconazole and/or other CYP3A4 inhibitors.</li>
                <li><strong>Peripheral Neuropathy:</strong> This has been reported in patients on long-term therapy with itraconazole. Monitor and promptly evaluate neurologic symptoms </li>
                <li><strong>Hearing loss:</strong> Reversible or permanent hearing loss has been reported in patients. Discontinue treatment if hearing loss occurs </li>
            </ul>
            <p class="mb-0 mb-2 mt-4"><strong>Adverse Reactions</strong></p>
            <p class="mb-4">Most common adverse reactions (incidence ≥ 1%) are nausea, rash, vomiting, edema, headache, diarrhea, fatigue, fever, pruritus, hypertension, abnormal hepatic function, abdominal pain, dizziness, hypokalemia, anorexia, malaise, decreased libido, somnolence, albuminuria, and impotence.</p>
            <p class="mb-4"><strong>To report SUSPECTED ADVERSE REACTIONS, contact Mayne Pharma at <a href="tel:+18448258500">1-844-825-8500</a> or the FDA at 1-800-FDA-1088 or <a target="_blank" href="https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program"><u>www.fda.gov/medwatch.</u></a></strong></p>
            <p class="mb-0"><strong>For more information, please see full <a class="underline" target="_blank" href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=306352d1-9d5a-49ad-b72d-893b99546861&audience=professional"><u>Prescribing Information and Patient Information Leaflet.</u> </a></strong></p>
        </div>
    </div>
    <!-- REFERENCE SECTION START -->
    <div class="section pt-100 pb-100">
        <div class="container">
            <div class="references-block">
                <h2>References:</h2>
                <ul>
                    <li>TOLSURA® Product Information. Mayne Pharma. Greenville, NC. 12/2018.</li>              
                    <li>Abuhelwa AY, Foster DJ, Mudge S, Hayes D, Upton RN. Population pharmacokinetic modeling of itraconazole and hydroxyitraconazole for oral SUBA-itraconazole and sporanox capsule formulations in healthy subjects in fed and fasted states. Antimicrob Agents Chemother. 2015;59(9):5681-5696. doi:10.1128/AAC.00973-15.</li>
                    <li>Data on File. Mayne Pharma, Inc. 2017.</li>
                    <li>Lindsay J, Mudge S, Thompson GR 3rd. Effects of food and omeprazole on a novel formulation of super bioavailability itraconazole in healthy subjects. Antimicrob Agents Chemother. 2018; 62(12).</li>
                    <li>Data on File. Clinical study report MPG 016.</li>
                    <li>Mudge S, Burnett BP. Pharmacokinetic Analysis of SUBATM-itraconazole Capsules Compared to Conventional Itraconazole Capsules for a 3-Day Loading Dose Regimen and Afer 15 Days of Administration. Poster presented (#L0043) at 29th European Congress of Clinical Microbiology & Infectious Diseases, Amsterdam, Netherlands. April 13-16, 2019.</li>
                    <li>Data on File. Clinical study report MPG 017.</li>
                    <li>Thompson GR, et al. Antimicrob Agents Chemother. 2020;64(8):e00400-20.</li>
                    <li>Data on file. Mayne Pharma, Inc. Clinical study report MPG015.</li>
                    <li>Patterson TF, et al. Clin Infect Dis. 2016;63(4):433-442.</li>
                    <li>Limper AH, et al. Am J Respir Crit Care Med. 2011;183:96-128.</li>
                    <li>Chapman SW, Dismukes WE, Proia LA, et al. Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis. 2008;46(12)1801-1812.</li>
                    <li>Wheat LJ, Freifeld AG, Kleiman MB, et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45(7)807-825.</li>
                    <li>Denning DW, et al. Eur Respir J. 2016;47(1):45-68.</li>
                    <li>Badiee P, Hashemizadeh Z. Opportunistic invasive fungal infections: diagnosis & clinical management. Indian J Med Res. 2014;132(2):195-204.</li>
                    <li>Cornely OA. Aspergillus to Zygomycetes: causes, risk factors, prevention, and treatment of invasive fungal infections. Infection. 2008;36(4)296-313.</li>
                    <li>Lindsay J, et al. Antimicrob Agents Chemother. 2018;62(12)e01723-18.</li>
                    <li>Sporanox® Product Information. Janssen Pharmaceuticals, Inc. Titusville, NJ. May 2018.</li>
                    <li>Sporanox® oral solution Product Information. Janssen Pharmaceuticals, Inc. Titusville, NJ. Apr 2019.</li>
                    <li>Poirier JM, et al. Therapie. 1996;51(2):163-167.</li>
                </ul>
            </div>
        </div>
    </div>
</div>
<!-- REFERENCE SECTION START -->
    
<div id="isi" class="section">
    <div class="container pb-100">
        <div class="expand-collapse-isi">
            <a href="#"><img class="fa fa-plus expand-isi" src="https://awareness.tolsura.com/l/153741/2021-04-12/442dl8/153741/1618221207YVr2k8j6/plus__icon.jpg" alt="plus icon"></a>
            <a href="#"><img class="fa fa-minus collapse-isi expand-isi" src="https://awareness.tolsura.com/l/153741/2021-04-12/442dkx/153741/1618221206p3dCVT78/minus__icon.jpg" alt="minus icon"></a>
        </div>
        <p>Indications and Important <br class="d-block d-lg-none d-md-none">Safety Information</p>
        <div class="warning-box">
            <p class="mb-0"><strong>BOXED WARNING</strong> <br /><strong>WARNING: CONGESTIVE HEART FAILURE and DRUG INTERACTIONS</strong> </p>
            <ul class="bullet1 mb-1 mt-1">
            <li> » CONGESTIVE HEART FAILURE</li>
            </ul>
            <p class="mb-1 pl-3"><strong>TOLSURA can cause or exacerbate congestive heart failure (CHF). When itraconazole was administered intravenously to healthy human volunteers and dogs, negative inotropic effects were seen. </strong>If signs or symptoms
            of congestive heart failure occur or worsen during administration of TOLSURA, reassess the benefit and risk of
            continuing treatment.</p>
            <ul class="bullet1">
                <li>  » DRUG INTERACTIONS</li>
            </ul>
            <ul class="bullet2">
                <li>Co-administration of certain drugs that are metabolized by human CYP3A4 enzymes are contraindicated with
                    TOLSURA because plasma concentrations of such drugs are increased, which may also increase or prolong both the
                    pharmacologic effects and/or adverse reactions to these drugs.</li>
                <li>Co-administration with colchicine, fesoterodine and solifenacin is contraindicated in subjects with varying degrees of renal or hepatic impairment, and</li>
                <li>Co-administration with eligustat is contraindicated in subjects taking strong or moderate CYP2D6 inhibitors. </li>
                <li>Increased plasma concentrations of some of these drugs caused by co-administration with TOLSURA can lead to QT prolongation and/or ventricular tachyarrhythmias, including occurrences of torsades de pointes, a potentially fatal arrhythmia. </li>
            </ul>
        </div>
        <p class="mb-0"><strong>Indications and Usage</strong> </p>
        <p >TOLSURA is an azole antifungal indicated for the treatment of the following fungal infections in <strong>immunocompromised and non-immunocompromised</strong> adult patients:</p>           
        <ul class="bullet2 ml-2">
            <li>Blastomycosis, pulmonary and extrapulmonary</li>
            <li>Histoplasmosis, including chronic cavitary pulmonary disease and disseminated, non-meningeal histoplasmosis, and</li>
            <li>Aspergillosis, pulmonary and extrapulmonary, in patients who are intolerant of or who are refractory to amphotericin B therapy </li>
        </ul>
        <p class="mb-0 mb-2 mt-4"><strong>Limitations of Use:</strong></p>
            <p class="mb-0">TOLSURA is not indicated for the treatment of onychomycosis.</p>
            <p class="mb-0">TOLSURA is NOT interchangeable or substitutable with other itraconazole products.</p>
            <p class="mb-0 mb-2 mt-4"><strong>Contraindications</strong></p>
            <p class="mb-0">Co-administration with certain drugs that either affect metabolism of itraconazole or whose metabolism is affected by itraconazole Hypersensitivity to itraconazole</p>            
        <p class="mb-0 mb-2 mt-4"><strong>Warnings and Precautions</strong></p>
        <ul class="bullet2 ml-2">
            <li><strong>Hepatotoxicity:</strong> Serious hepatotoxicity, including liver failure and death, were reported with the use of itraconazole. Discontinue treatment if signs of liver dysfunction occur</li>
            <li><strong>Cardiac Dysrhythmias:</strong> Life-threatening cardiac dysrhythmias and/or sudden death have occurred in patients using certain drugs that are metabolized by human CYP450 enzymes concomitantly with oral itraconazole and/or other CYP3A4 inhibitors.</li>
            <li><strong>Peripheral Neuropathy:</strong> This has been reported in patients on long-term therapy with itraconazole. Monitor and promptly evaluate neurologic symptoms </li>
            <li><strong>Hearing loss:</strong> Reversible or permanent hearing loss has been reported in patients. Discontinue treatment if hearing loss occurs </li>
        </ul>
        <p class="mb-0 mb-2 mt-4"><strong>Adverse Reactions</strong></p>
        <p class="mb-4">Most common adverse reactions (incidence ≥ 1%) are nausea, rash, vomiting, edema, headache, diarrhea, fatigue, fever, pruritus, hypertension, abnormal hepatic function, abdominal pain, dizziness, hypokalemia, anorexia, malaise, decreased libido, somnolence, albuminuria, and impotence.</p>
        <p class="mb-4"><strong>To report SUSPECTED ADVERSE REACTIONS, contact Mayne Pharma at <a href="tel:+18448258500">1-844-825-8500</a> or the FDA at 1-800-FDA-1088 or <a target="_blank" href="https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program"><u>www.fda.gov/medwatch.</u></a></strong></p>
        <p class="mb-0"><strong>For more information, please see full <a class="underline" target="_blank" href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=306352d1-9d5a-49ad-b72d-893b99546861&audience=professional"><u>Prescribing Information and Patient Information Leaflet.</u> </a></strong></p>
    </div>
</div>
<!-- ISI BLOCK END -->

<!-- FOOTER START -->
<footer>
    <div class="container">
        <div class="row">
            <div class="col-lg-3">
                <a href="#" class="footer__logo mb-lg-0 mb-4">
                    <img src="assets/img/TOLSURA_DARK_LOGO.png" alt="Tolsura">
                </a>
            </div>
            <div class="col-lg-5">
                <div class="footer__links mb-lg-0 mb-4">
                    <ul>
                        <li><a href="#">HOME</a></li>
                        <li><a href="#">INFECTIONS OVERVIEW</a></li>
                        <li><a href="#">ABOUT TOLSURA</a></li>
                        <li><a href="#">BENEFITS OF TOLSURA</a></li>
                        <li><a href="#">SAFETY</a></li>
                        <li><a href="#">DOSING</a></li>
                        <li><a href="#">SAVINGS</a></li>
                    </ul>
                </div>
            </div>
            <div class="col-lg-4">
                <div class="customer__service mb-4">
                    Customer Service <div class="d-block"><a href="tel:+18003448661">+1 800 344 8661</a></div>
                </div>
                <div class="address mb-4">
                    1240 Sugg Parkway, Greenville, NC 27834
                </div>
                <div class="medical__info mb-lg-3 mb-4">
                    Medical Information & Adverse Drug Events Reporting
                </div>
                <div class="report">
                    To report a suspected adverse reaction from one of our products, please contact Mayne Pharma at <a href="tel:+18448258500">1-844-825-8500</a> or the FDA at <a href="tel:+1800FDA1088">1-800-FDA-1088</a> or <a href="http://www.fda.gov/medwatch" target="_blank" >www.fda.gov/medwatch</a>.
                </div>
            </div>
        </div>
        <div class="footer__bottom pt-150">
            <div class="row">
                <div class="col-12">
                    <div class="social__icon">
                        <ul>
                            <li><a href="#"><img src="assets/img/Icons_brand_twitter.svg" alt="Twitter"></a></li>
                            <li><a href="#"><img src="assets/img/Icons_brand_facebook.svg" alt="Facebook"></a></li>
                        </ul>
                    </div>
                </div>
                <div class="col-12">
                    <div class="footer__copyright">
                        <div class="row">
                            <div class="col-lg-6">
                                <div class="d-flex">
                                    <div class="copyright__text">© 2021 <a href="https://www.maynepharma.com/" target="_blank">Mayne Pharma</a>. All Rights Reserved.</div>
                                    <div class="pm__tool">PM-US-TOL-0002. 01/19</div>
                                </div>
                            </div>
                            <div class="col-lg-6">
                                <ul class="float-lg-right">
                                    <li><a href="https://www.maynepharma.com/privacy-policy/" target="_blank">Privacy Policy</a></li>
                                    <li><a href="https://www.maynepharma.com/terms-and-conditions/" target="_blank">Terms of Use</a></li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>
</footer>
<!-- FOOTER END -->


<!-- JS Script -->
<script src="assets/js/jquery-3.5.1.min.js"></script>
<script src="assets/js/bootstrap.min.js"></script>
<script src="assets/js/lazysizes.min.js"></script>
<script src="assets/js/ls.bgset.min.js"></script>
<script src="assets/js/custom.js"></script>
</body>
</html>
